Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HUNGER

Showing results (1081-1090 of 1,174) with videos related to

Pageof 118
Sort By:
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
JAMA|January 30, 2009
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
Blood|February 28, 2012
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group studyI-Ming Chen, Richard C Harvey, Charles G Mullighan, et al.
Nature Communications|February 11, 2023
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticlesVerena Turco, Kira Pfleiderer, Jessica Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Leukemia|January 19, 2017
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaS E Karol, E Larsen, C Cheng, et al.
The Lancet. Oncology|August 26, 2017
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialMarianne E Pavel, Simron Singh, Jonathan R Strosberg, et al.
Pageof 118

Showing results (1081-1090 of 1,174) with videos related to

Sort By:
Pageof 118
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
JAMA|January 30, 2009
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
Blood|February 28, 2012
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group studyI-Ming Chen, Richard C Harvey, Charles G Mullighan, et al.
Nature Communications|February 11, 2023
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticlesVerena Turco, Kira Pfleiderer, Jessica Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Leukemia|January 19, 2017
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaS E Karol, E Larsen, C Cheng, et al.
The Lancet. Oncology|August 26, 2017
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialMarianne E Pavel, Simron Singh, Jonathan R Strosberg, et al.
Pageof 118